LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | JW-7-24-1 | 10 | uM | LJP6 | 1 | B19 | 72 | hr | 1476 | 1296 | 3413 | 0.3797 | -0.1024 |
| SK-BR-3 | JW-7-24-1 | 10 | uM | LJP6 | 2 | B19 | 72 | hr | 1476 | 1129 | 3783 | 0.2984 | -0.1795 |
| SK-BR-3 | JW-7-24-1 | 10 | uM | LJP6 | 3 | B19 | 72 | hr | 1476 | 797 | 3734 | 0.2134 | -0.3692 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP6 | 1 | I06 | 72 | hr | 1476 | 3730 | 3413 | 1.0928 | 1.1523 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP6 | 2 | I06 | 72 | hr | 1476 | 4128 | 3783 | 1.0911 | 1.1326 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP6 | 3 | I06 | 72 | hr | 1476 | 3329 | 3734 | 0.8915 | 0.8356 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 1476 | 3682 | 3788 | 0.9719 | 0.9584 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP5 | 2 | D06 | 72 | hr | 1476 | 3762 | 3731 | 1.0083 | 1.0123 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 1476 | 3747 | 3796 | 0.9869 | 0.9808 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP6 | 1 | I05 | 72 | hr | 1476 | 3106 | 3413 | 0.9100 | 0.8498 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP6 | 2 | I05 | 72 | hr | 1476 | 3838 | 3783 | 1.0144 | 1.0212 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP6 | 3 | I05 | 72 | hr | 1476 | 3139 | 3734 | 0.8406 | 0.7567 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 1476 | 3746 | 3788 | 0.9887 | 0.9834 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 1476 | 3695 | 3731 | 0.9903 | 0.9855 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 1476 | 3868 | 3796 | 1.0188 | 1.0275 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP6 | 1 | I04 | 72 | hr | 1476 | 3536 | 3413 | 1.0360 | 1.0593 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP6 | 2 | I04 | 72 | hr | 1476 | 3612 | 3783 | 0.9547 | 0.9328 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP6 | 3 | I04 | 72 | hr | 1476 | 3753 | 3734 | 1.0051 | 1.0076 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 1476 | 3397 | 3788 | 0.8966 | 0.8457 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP5 | 2 | D04 | 72 | hr | 1476 | 3834 | 3731 | 1.0275 | 1.0411 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP5 | 3 | D04 | 72 | hr | 1476 | 3565 | 3796 | 0.9390 | 0.9097 |
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP6 | 1 | I03 | 72 | hr | 1476 | 3209 | 3413 | 0.9402 | 0.9005 |
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP6 | 2 | I03 | 72 | hr | 1476 | 3258 | 3783 | 0.8611 | 0.7914 |
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP6 | 3 | I03 | 72 | hr | 1476 | 3218 | 3734 | 0.8618 | 0.7896 |
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP5 | 1 | D03 | 72 | hr | 1476 | 2991 | 3788 | 0.7895 | 0.6807 |